Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ALVOAlvotech SA	$2.50bn	26	n/a
FOLDAmicus Therapeutics	$2.46bn	n/a	n/a
IBRXImmunitybio	$2.46bn	n/a	n/a
VCYTVeracyte	$2.43bn	58.66	n/a
LBPHLongboard Pharmaceuticals	$2.34bn	n/a	n/a
CELCCelcuity	$2.33bn	n/a	n/a
DICEDice Therapeutics	$2.27bn	n/a	n/a
BLTEBelite Bio	$2.26bn	n/a	n/a
DCPHDeciphera Pharmaceuticals	$2.21bn	n/a	n/a
IDYAIdeaya Biosciences	$2.16bn	n/a	n/a
AGIOAgios Pharmaceuticals	$2.14bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$2.10bn	n/a	n/a
TVTXTravere Therapeutics	$2.09bn	n/a	n/a
BEAMBeam Therapeutics	$2.08bn	n/a	n/a
IRONDisc Medicine	$2.08bn	n/a	n/a
DNLIDenali Therapeutics	$2.07bn	n/a	n/a
ADPTAdaptive Biotechnologies	$1.92bn	n/a	n/a
DYNDyne Therapeutics	$1.87bn	n/a	n/a
BLUBELLUS Health	CA$2.47bn	n/a	n/a
FUSNFusion Pharmaceuticals	$1.83bn	n/a	n/a